Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 107

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 107
---
 last day of each of the Company’s fiscal quarters, including certain financial ratios.The Company paid $3.2 million in arrangement and up-front fees on the Closing Date. The Company may voluntarily prepay the outstanding revolving loans under the Revolving Credit Facility in whole or in part without premium or penalty provided that the prepayment shall be in certain amounts as specified therein. The Company is currently evaluating the Revolving Credit Facility to determine the impact on its consolidated financial statements and related disclosures. As of the date of this filing, the Company has not drawn upon the Revolving Credit Facility.

F-44